Arginine or citrulline associated with a statin stimulates nitric oxide production in bovine aortic endothelial cells

European Journal of Pharmacology

Volumn 670, Issue 2-3, 2011, Pages 566-570

  Berthe, Marie Clotilde ^a,b   Bernard, Mélisande ^a   Rasmusen, Carole ^a   Darquy, Sylviane ^a   Cynober, Luc ^a,c   Couderc, Rémy ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c HÔTEL DIEU   (France)

Author keywords

Arginine; Citrulline; Endothelial cell; eNOS; Nitric oxide

Indexed keywords

ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; CAVEOLIN 1; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; SIMVASTATIN;

ANIMAL CELL; ARTICLE; BOVINE AORTIC ENDOTHELIAL CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIUM CELL; GENE EXPRESSION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; ARGININE; ARGININOSUCCINATE LYASE; CATTLE; CAVEOLIN 1; CITRULLINE; DRUG INTERACTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; SIMVASTATIN;

EID: 80755153636     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.08.018     Document Type: Article

References (35)

1. F.E. Barr, R.G. Tirona, M.B. Taylor, G. Rice, J. Arnold, G. Cunningham, H.A. Smith, A. Campbell, J.A. Canter, K.G. Christian, D.C. Drinkwater, F. Scholl, A. Kavanaugh-McHugh, and M.L. Summar Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension J. Thorac. Cardiovasc. Surg. 134 2007 319 326 (Pubitemid 47088581)
2. S.M. Bode-Boger, R.H. Boger, A. Galland, D. Tsikas, and J.C. Frolich l-arginine-induced vasodilation in healthy humans: pharmacokinetic- pharmacodynamic relationship Br. J. Clin. Pharmacol. 46 1998 489 497 (Pubitemid 28484737)
3. S.M. Bode-Boger, F. Scalera, and L.J. Ignarro The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio Pharmacol. Ther. 114 2007 295 306 (Pubitemid 46843253)
4. A. Brouet, P. Sonveaux, C. Dessy, S. Moniotte, J.L. Balligand, and O. Feron Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins Circ. Res. 89 2001 866 873 (Pubitemid 34627891)
5. T. de Frutos, L.S. de Miguel, M. Garcia-Duran, F. Gonzalez-Fernandez, J.A. Rodriguez-Feo, M. Monton, J. Guerra, J. Farre, S. Casado, and A. Lopez-Farre NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha Am. J. Physiol. 277 1999 H1317 H1325 (Pubitemid 29522660)
6. W. Dichtl, J. Dulak, M. Frick, H.F. Alber, S.P. Schwarzacher, M.P. Ares, J. Nilsson, O. Pachinger, and F. Weidinger HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 23 2003 58 63 (Pubitemid 36091626)
7. O. Feron, C. Dessy, J.P. Desager, and J.L. Balligand Hydroxy- methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance Circulation 103 2001 113 118 (Pubitemid 32050445)
8. B.R. Flam, P.J. Hartmann, M. Harrell-Booth, L.P. Solomonson, and D.C. Eichler Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase Nitric Oxide 5 2001 187 197 (Pubitemid 34142742)
9. B.R. Flam, D.C. Eichler, and L.P. Solomonson Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle Nitric Oxide 17 2007 115 121 (Pubitemid 47513850)
10. M.T. Gewaltig, and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc. Res. 55 2002 250 260 (Pubitemid 34775275)
11. M.S. Goligorsky, H. Li, S. Brodsky, and J. Chen Relationships between caveolae and eNOS: everything in proximity and the proximity of everything Am. J. Physiol. Renal Physiol. 283 2002 F1 F10 (Pubitemid 34680466)
12. B.L. Goodwin, L.C. Pendleton, M.M. Levy, L.P. Solomonson, and D.C. Eichler Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1115 H1121 (Pubitemid 47254212)
13. G.K. Grimble Adverse gastrointestinal effects of arginine and related amino acids J. Nutr. 137 2007 1693S 1701S (Pubitemid 46855532)
14. A. Husson, C. Brasse-Lagnel, A. Fairand, S. Renouf, and A. Lavoinne Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle Eur. J. Biochem. 270 2003 1887 1899 (Pubitemid 36560809)
15. M. Igel, T. Sudhop, and K. von Bergmann Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin J. Clin. Pharmacol. 42 2002 835 845 (Pubitemid 34803847)
16. M. Ii, and D.W. Losordo Statins and the endothelium Vascul. Pharmacol. 46 2007 1 9 (Pubitemid 44856372)
17. L. Kalinowski, L.W. Dobrucki, V. Brovkovych, and T. Malinski Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin Circulation 105 2002 933 938 (Pubitemid 34184570)
18. I. Kosmidou, J.P. Moore, M. Weber, and C.D. Searles Statin treatment and 3′ polyadenylation of eNOS mRNA Arterioscler. Thromb. Vasc. Biol. 27 2007 2642 2649 (Pubitemid 350158917)
19. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135 (Pubitemid 28152885)
20. C. Li, W. Huang, M.B. Harris, J.M. Goolsby, and R.C. Venema Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport Biochem. J. 386 2005 567 574 (Pubitemid 40445882)
21. V.W. Liu, and P.L. Huang Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice Cardiovasc. Res. 77 2008 19 29 (Pubitemid 351195168)
22. K.K. McDonald, S. Zharikov, E.R. Block, and M.S. Kilberg A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox" J. Biol. Chem. 272 1997 31213 31216 (Pubitemid 28013248)
23. T.P. Misko, R.J. Schilling, D. Salvemini, W.M. Moore, and M.G. Currie A fluorometric assay for the measurement of nitrite in biological samples Anal. Biochem. 214 1993 11 16 (Pubitemid 23300346)
24. C. Moinard, I. Nicolis, N. Neveux, S. Darquy, S. Benazeth, and L. Cynober Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study Br. J. Nutr. 99 2008 855 862 (Pubitemid 351351641)
25. M. Pelat, C. Dessy, P. Massion, J.P. Desager, O. Feron, and J.L. Balligand Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo Circulation 107 2003 2480 2486 (Pubitemid 36605232)
26. R.B. Preli, K.P. Klein, and D.M. Herrington Vascular effects of dietary l-arginine supplementation Atherosclerosis 162 2002 1 15 (Pubitemid 34327336)
27. C. Rasmusen, C. Moinard, C. Martin, V. Tricottet, L. Cynober, and R. Couderc l-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits Br. J. Nutr. 97 2007 1083 1089 (Pubitemid 46925360)
28. I.F. Schwartz, R. Ayalon, T. Chernichovski, R. Reshef, G. Chernin, T. Weinstein, A. Litvak, Y. Levo, and D. Schwartz Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats Kidney Int. 69 2006 298 303 (Pubitemid 43323080)
29. L.J. Shen, K. Beloussow, and W.C. Shen Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway Biochem. Pharmacol. 69 2005 97 104 (Pubitemid 39592876)
30. H.A. Smith, J.A. Canter, K.G. Christian, D.C. Drinkwater, F.G. Scholl, B.W. Christman, G.D. Rice, F.E. Barr, and M.L. Summar Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline J. Thorac. Cardiovasc. Surg. 132 2006 58 65
31. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 21 2001 1712 1719 (Pubitemid 34219772)
32. O. Tangphao, M. Grossmann, S. Chalon, B.B. Hoffman, and T.F. Blaschke Pharmacokinetics of intravenous and oral l-arginine in normal volunteers Br. J. Clin. Pharmacol. 47 1999 261 266 (Pubitemid 29131339)
33. C.J. Vaughan, A.M. Gotto, and C.T. Basson Jr. The evolving role of statins in the management of atherosclerosis J. Am. Coll. Cardiol. 35 2000 1 10 (Pubitemid 30061252)
34. J. Wang, Z. Xu, I. Kitajima, and Z. Wang Effects of different statins on endothelial nitric oxide synthase and AKT phosphorylation in endothelial cells Int. J. Cardiol. 127 2008 33 39
35. S. Wolfrum, K.S. Jensen, and J.K. Liao Endothelium-dependent effects of statins Arterioscler. Thromb. Vasc. Biol. 23 2003 729 736 (Pubitemid 36566160)